Skip to content

Study · Not a test of the peptide alone · 1996

4 results

[Evaluation of the effectiveness of immunomodulators in the treatment of patients with postoperative suppurative-septic complications].

Bulava GV, Nikulina VP

Khirurgiia1 Jan 1996

PMID8754918 (opens in a new tab)PepBankPUB-08754918
Publisher pageAsk about this study
Jump to 4 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study4

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone4

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with postoperative septic complications, reactions to Thymalin and T-activin differed between patients.

    In plain wordsIn patients with postoperative septic complications, responses to Thymalin and T-activin differed between patients.

    Peptide
    Thymalin
    Outcome
    Direction not reportedVariation in treatment response
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    There were differences in reaction to T-activin and Thymalin between various patients with septic postoperative complications.
    1 context sentence
    Summary · context
    The influence of immunoactive medicines on the cell immunity have been studied.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with postoperative septic complications, combinations of Thymalin with immunoglobulins or immune plasmas stimulated T-cells, whereas Thymalin alone did not.

    In plain wordsIn postoperative septic complications, Thymalin stimulated T-cells only when combined with immunoglobulins or immune plasmas.

    Peptide
    Thymalin
    Outcome
    IncreaseT-cell stimulation
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    Thymalin stimulated T-cells while acting with immunoglobulins or immune plasmas only.
    2 context sentences
    Summary · context
    There were differences in reaction to T-activin and Thymalin between various patients with septic postoperative complications.
    Summary · context
    The influence of immunoactive medicines on the cell immunity have been studied.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  3. 03HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In postoperative septic complications, pooled immunomodulators including Thymalin produced a greater clinical effect when combined with vaccines.

    In plain wordsIn postoperative septic complications, immunomodulators including Thymalin had a greater clinical effect with vaccines than without vaccines.

    Peptide
    Thymalin
    Outcome
    IncreaseClinical effect with vaccines
    Study

    n: not reported in source

    Comparator
    Immunomodulators without vaccines
    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    The positive clinical effect was more impressive when immunomodulators were used in combinations with the vaccines
    2 context sentences
    Summary · context
    There were differences in reaction to T-activin and Thymalin between various patients with septic postoperative complications.
    Summary · context
    The influence of immunoactive medicines on the cell immunity have been studied.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  4. 04HumanNot a test of Thymalin aloneNon-randomized trialOther

    In postoperative septic complications, clinical effects of pooled immunomodulator combinations did not fully correlate with changes in cell immunity parameters.

    In plain wordsIn postoperative septic complications, clinical effects of immunomodulator combinations including Thymalin did not fully correlate with changes in cell immunity.

    Peptide
    Thymalin
    Outcome
    Direction not reportedClinical effect and cell immunity correlation
    Study

    n: not reported in source

    Outcome group
    Immune response · Immune and inflammation

    Source sentences

    Summary
    The positive clinical effect was more impressive when immunomodulators were used in combinations with the vaccines; still it did not correlate completely with the dynamics of the cell immunity parameters.
    2 context sentences
    Summary · context
    There were differences in reaction to T-activin and Thymalin between various patients with septic postoperative complications.
    Summary · context
    The influence of immunoactive medicines on the cell immunity have been studied.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.